Anchiano Therapeutics, formerly known as Biocancell, is a clinical-stage biotechnology company developing a targeted gene therapy to improve the standard treatment for early-stage bladder cancer.
from RTT - Biotech http://bit.ly/2SnP2Za
via IFTTT
No comments:
Post a Comment